-
Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction
Juni, R. P., Al-Shama, R., Kuster, D. W. D., van der Velden, J., Hamer, H. M., Vervloet, M. G., Eringa, E. C., Koolwijk, P. & van Hinsbergh, V. W. M., May 2021, In: Kidney international. 99, 5, p. 1088-1101 14 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure
Raso, A., Dirkx, E., Philippen, L. E., Fernandez-Celis, A., de Majo, F., Sampaio-Pinto, V., Sansonetti, M., Juni, R., el Azzouzi, H., Calore, M., Bitsch, N., Olieslagers, S., Oerlemans, M. I. F. J., Huibers, M. M., de Weger, R. A., Reckman, Y. J., Pinto, Y. M., Zentilin, L., Zacchigna, S. & Giacca, M. & 3 others, , 6 Mar 2019, In: Molecular therapy. 27, 3, p. 584-599Research output: Contribution to journal › Article* › Academic › peer-review
-
Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells
Uthman, L., Homayr, A., Juni, R. P., Spin, E. L., Kerindongo, R., Boomsma, M., Hollmann, M. W., Preckel, B., Koolwijk, P., van Hinsbergh, V. W. M., Zuurbier, C. J., Albrecht, M. & Weber, N. C., 2019, In: Cellular physiology and biochemistry. 53, 5, p. 865-886Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
